These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 22147937)

  • 1. Prognostic immune markers in non-small cell lung cancer--letter.
    Pandey JP
    Clin Cancer Res; 2011 Dec; 17(24):7835; author reply 7836. PubMed ID: 22147937
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers.
    Usó M; Jantus-Lewintre E; Bremnes RM; Calabuig S; Blasco A; Pastor E; Borreda I; Molina-Pinelo S; Paz-Ares L; Guijarro R; Martorell M; Forteza J; Camps C; Sirera R
    Oncotarget; 2016 Aug; 7(33):52849-52861. PubMed ID: 27463005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic immune markers in non-small cell lung cancer.
    Suzuki K; Kachala SS; Kadota K; Shen R; Mo Q; Beer DG; Rusch VW; Travis WD; Adusumilli PS
    Clin Cancer Res; 2011 Aug; 17(16):5247-56. PubMed ID: 21659461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice.
    Taverna S; Giallombardo M; Gil-Bazo I; Carreca AP; Castiglia M; Chacártegui J; Araujo A; Alessandro R; Pauwels P; Peeters M; Rolfo C
    Oncotarget; 2016 May; 7(19):28748-60. PubMed ID: 26919248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a reverse transcription-polymerase chain reaction-based five-gene signature in non-small cell lung cancer.
    Ruco L; Scarpino S; Natoli G
    J Thorac Oncol; 2009 May; 4(5):670. PubMed ID: 19395916
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical implication of microrna for lung cancer.
    Wang Y; Zhang X; Liu L; Li H; Yu J; Wang C; Ren X
    Cancer Biother Radiopharm; 2013 May; 28(4):261-7. PubMed ID: 23496233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invited commentary.
    Lee HS; Zo JI
    Ann Thorac Surg; 2012 May; 93(5):1613. PubMed ID: 22541191
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic polymorphisms and non-small-cell lung cancer: future paradigms.
    de Mello RA
    Einstein (Sao Paulo); 2014; 12(4):524-6. PubMed ID: 25628210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hypoxic tumor microenvironment: driving the tumorigenesis of non-small-cell lung cancer.
    Foster JG; Wong SC; Sharp TV
    Future Oncol; 2014 Dec; 10(16):2659-74. PubMed ID: 25531051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invited commentary.
    Antonoff MB
    Ann Thorac Surg; 2015 May; 99(5):1754. PubMed ID: 25952203
    [No Abstract]   [Full Text] [Related]  

  • 11. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
    Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving Treatment Options for Lung Cancer.
    Morgensztern D; Herbst RS
    Hematol Oncol Clin North Am; 2017 Feb; 31(1):xiii-xiv. PubMed ID: 27912837
    [No Abstract]   [Full Text] [Related]  

  • 13. Morphology and a limited number of immunohistochemical markers may efficiently subtype non-small-cell lung cancer.
    Rossi G; Papotti M; Barbareschi M; Graziano P; Pelosi G
    J Clin Oncol; 2009 Oct; 27(28):e141-2; author reply e143-4. PubMed ID: 19720885
    [No Abstract]   [Full Text] [Related]  

  • 14. The spatial transcriptomic landscape of non-small cell lung cancer brain metastasis.
    Zhang Q; Abdo R; Iosef C; Kaneko T; Cecchini M; Han VK; Li SS
    Nat Commun; 2022 Oct; 13(1):5983. PubMed ID: 36216799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of clinical bioinformatics in lung cancer-specific biomarkers.
    Wu D; Wang X
    Cancer Metastasis Rev; 2015 Jun; 34(2):209-16. PubMed ID: 25933723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular diagnostics in advanced NSCLC: trying to maximize a non-ideal situation.
    Lim EH; Tan P
    J Thorac Oncol; 2007 Aug; 2(8):782. PubMed ID: 17762350
    [No Abstract]   [Full Text] [Related]  

  • 17. MicroRNA-1976 functions as a tumor suppressor and serves as a prognostic indicator in non-small cell lung cancer by directly targeting PLCE1.
    Chen G; Hu J; Huang Z; Yang L; Chen M
    Biochem Biophys Res Commun; 2016 May; 473(4):1144-1151. PubMed ID: 27063799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome Instability Drives Tumor Evolution.
    Cancer Discov; 2017 Jun; 7(6):546. PubMed ID: 28487325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AKR1B10 is associated with smoking and smoking-related non-small-cell lung cancer.
    Kang MW; Lee ES; Yoon SY; Jo J; Lee J; Kim HK; Choi YS; Kim K; Shim YM; Kim J; Kim H
    J Int Med Res; 2011; 39(1):78-85. PubMed ID: 21672310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined analysis identifies six genes correlated with augmented malignancy from non-small cell to small cell lung cancer.
    Zhang C; Min L; Zhang L; Ma Y; Yang Y; Shou C
    Tumour Biol; 2016 Feb; 37(2):2193-207. PubMed ID: 26349752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.